IS7811A - Aðferðir og prófefni til að meðhöndla sjúkdóma ogkvilla sem tengjast auknu magni af bólguvaldandi frumuboðum - Google Patents

Aðferðir og prófefni til að meðhöndla sjúkdóma ogkvilla sem tengjast auknu magni af bólguvaldandi frumuboðum

Info

Publication number: IS7811A
Authority: IS; Iceland
Prior art keywords: diseases; treatment; methods; disorders associated; increased levels
Prior art date: 2002-09-24

Application number

IS7811A

Other languages

English (en)

Inventor

Manivasakam Palaniyandi

Smith Brendan

Fong Jason

A. Auspitz Benjamin

James Nichols M.

Keith Curtis

R. Zimmermann Grant

B. Brasher Bradley

Sachs Noah

W. Chappell Todd

Grau Daniel

Roydon Jost-Price Edward

Original Assignee

Combinatorx, Incorporated

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2002-09-24

Filing date

2005-04-19

Publication date

2005-04-19

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=32074779&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=IS7811(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2005-04-19 Application filed by Combinatorx, Incorporated filed Critical Combinatorx, Incorporated

2005-04-19 Publication of IS7811A publication Critical patent/IS7811A/is

Links

208000037765 diseases and disorders Diseases 0.000 title 1
210000004969 inflammatory cell Anatomy 0.000 title 1
238000000034 method Methods 0.000 title 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
- A61K38/13—Cyclosporins
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/04—Drugs for skeletal disorders for non-specific disorders of the connective tissue
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
Veterinary Medicine (AREA)
Chemical & Material Sciences (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Immunology (AREA)
Biomedical Technology (AREA)
Pulmonology (AREA)
Epidemiology (AREA)
Physical Education & Sports Medicine (AREA)
Neurology (AREA)
Dermatology (AREA)
Rheumatology (AREA)
Neurosurgery (AREA)
Gastroenterology & Hepatology (AREA)
Obesity (AREA)
Psychiatry (AREA)
Child & Adolescent Psychology (AREA)
Hematology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Diabetes (AREA)
Hospice & Palliative Care (AREA)
Orthopedic Medicine & Surgery (AREA)
Pain & Pain Management (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Steroid Compounds (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

IS7811A 2002-09-24 2005-04-19 Aðferðir og prófefni til að meðhöndla sjúkdóma ogkvilla sem tengjast auknu magni af bólguvaldandi frumuboðum IS7811A (is)

Applications Claiming Priority (6)

Application Number	Priority Date	Filing Date	Title
US41304002P	2002-09-24	2002-09-24
US41726102P	2002-10-09	2002-10-09
US42752602P	2002-11-19	2002-11-19
US42742402P	2002-11-19	2002-11-19
US46475303P	2003-04-23	2003-04-23
PCT/US2003/030156 WO2004030618A2 (en)	2002-09-24	2003-09-24	Methods and reagents for the treatment of diseases and disorders associated with increased levels of proinflammatory cytokines

Publications (1)

Publication Number	Publication Date
IS7811A true IS7811A (is)	2005-04-19

Family

ID=32074779

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
IS7811A IS7811A (is)	2002-09-24	2005-04-19	Aðferðir og prófefni til að meðhöndla sjúkdóma ogkvilla sem tengjast auknu magni af bólguvaldandi frumuboðum

Country Status (12)

Country	Link
EP (1)	EP1553955A4 (is)
JP (1)	JP2006503905A (is)
AR (1)	AR041386A1 (is)
AU (1)	AU2003299196A1 (is)
BR (1)	BR0314713A (is)
CA (1)	CA2509526A1 (is)
HR (1)	HRP20050355A2 (is)
IS (1)	IS7811A (is)
MX (1)	MXPA05003152A (is)
NO (1)	NO20051669L (is)
TW (1)	TW200422042A (is)
WO (1)	WO2004030618A2 (is)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
WO2004073614A2 (en) *	2003-02-14	2004-09-02	Combinatorx, Incorporated	Combination therapy for the treatment of immunoinflammatory disorders
KR20060076319A (ko) *	2003-09-24	2006-07-04	콤비네이토릭스, 인코포레이티드	약물 조합들을 투여하는 치료 요법
WO2005115455A2 (en) *	2004-05-17	2005-12-08	Combinatorx, Incorporated	Methods and reagents for the treatment of immunoinflammatory disorders
CN101060860B (zh) *	2004-11-19	2013-07-17	Msd欧斯股份有限公司	用于治疗抑郁症的包含选择性5-羟色胺再摄取抑制剂和糖皮质激素受体拮抗剂的药物组合
AU2011236053B2 (en) *	2004-11-19	2014-06-26	Merck Sharpe & Dohme B.V.	Drug combination comprising a selective serotonin reuptake inhibitor and a glucocorticoid receptor antagonist for the treatment of depression
SI1719507T1 (sl) *	2005-04-13	2010-11-30	Astion Dev As	Beta adrenoceptor agonisti za zdravljenje bolezni veznega tkiva kože
JP4832806B2 (ja) *	2005-06-03	2011-12-07	久光製薬株式会社	経皮投与製剤
TW200711649A (en) *	2005-06-17	2007-04-01	Combinatorx Inc	Combination therapy for the treatment of immunoinflammatory disorders
CN101568331A (zh) *	2006-09-08	2009-10-28	奥尔制药有限公司	减少或缓解消化道炎症的方法
US20080064709A1 (en) *	2006-09-11	2008-03-13	Duke University	Methods and compositions for the treatment of vascular depression
GB0701171D0 (en) *	2007-01-22	2007-02-28	Imp Innovations Ltd	Compositions and uses thereof
WO2010098230A1 (ja) *	2009-02-27	2010-09-02	久光製薬株式会社	経皮投与製剤
PT117765B (pt) *	2022-01-28	2025-04-04	Faculdade De Farmacia Da Univ De Lisboa	Formulação tópica de fluvoxamina para o tratamento de psoríase
TW202423434A (zh) *	2022-10-07	2024-06-16	瑞士商歐庫利斯營運股份有限公司	mTOR抑制劑的點眼劑微懸液

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP0611302B1 (en) *	1991-10-15	2000-03-29	MULLARKEY, Michael F.	Receptors for treating late phase inflammatory responses
GB9603137D0 (en) *	1996-02-15	1996-04-17	Merck Sharp & Dohme	Therapeutic agents
ES2259746T3 (es) *	1996-07-15	2006-10-16	Alza Corporation	Nuevas formulaciones para la administracion transdermica de fluoxetina.
WO1998041232A2 (en) *	1997-03-18	1998-09-24	Basf Aktiengesellschaft	Compositions for modulating responsiveness to corticosteroids
US6281248B1 (en) *	2000-02-16	2001-08-28	Magda Abdel Fattah Ahmed	Composition for treating asthma
IL139975A0 (en) *	2000-11-29	2002-02-10	Univ Ramot	Anti proliferative drugs

2003
- 2003-09-24 HR HR20050355A patent/HRP20050355A2/hr not_active Application Discontinuation
- 2003-09-24 WO PCT/US2003/030156 patent/WO2004030618A2/en not_active Ceased
- 2003-09-24 AR ARP030103484A patent/AR041386A1/es unknown
- 2003-09-24 CA CA002509526A patent/CA2509526A1/en not_active Abandoned
- 2003-09-24 TW TW092126503A patent/TW200422042A/zh unknown
- 2003-09-24 BR BR0314713-4A patent/BR0314713A/pt not_active IP Right Cessation
- 2003-09-24 MX MXPA05003152A patent/MXPA05003152A/es not_active Application Discontinuation
- 2003-09-24 JP JP2005500317A patent/JP2006503905A/ja active Pending
- 2003-09-24 AU AU2003299196A patent/AU2003299196A1/en not_active Abandoned
- 2003-09-24 EP EP03756864A patent/EP1553955A4/en not_active Withdrawn
2005
- 2005-04-04 NO NO20051669A patent/NO20051669L/no not_active Application Discontinuation
- 2005-04-19 IS IS7811A patent/IS7811A/is unknown

Also Published As

Publication number	Publication date
NO20051669L (no)	2005-06-10
BR0314713A (pt)	2005-07-26
TW200422042A (en)	2004-11-01
JP2006503905A (ja)	2006-02-02
HRP20050355A2 (en)	2005-10-31
CA2509526A1 (en)	2004-04-15
AU2003299196A1 (en)	2004-04-23
MXPA05003152A (es)	2006-04-27
AR041386A1 (es)	2005-05-18
EP1553955A2 (en)	2005-07-20
EP1553955A4 (en)	2008-11-05
WO2004030618A3 (en)	2005-04-07
WO2004030618A2 (en)	2004-04-15

Publication	Publication Date	Title
IS8451A (is)	2006-05-11	Aðferðir og hvarfefni til að meðhöndla ónæmisbólgusjúkdóma
IS8410A (is)	2006-04-12	Aðferðir og hvarfefni til að meðhöndla ónæmisbólgusjúkdóma
CY2021009I1 (el)	2021-10-15	Αντισωματα αντι-ρ-σελεκτινης και μεθοδοι χρησης αυτων στην αντιμετωπιση φλεγμονωδων νοσων
IL183827A0 (en)	2007-09-20	Novel heterocyclic compounds useful for the treatment of inflammatory and allergic disorders
DK1644021T3 (da)	2012-10-29	Fremgangsmåder og sammensætninger til behandlingen af gastrointestinale sygdomme
DK1755743T3 (da)	2013-06-10	Beta-hydroxybutyrat og derivater til behandling af depression og angst
SI1608374T1 (sl)	2009-04-30	Derivati 2-fenoksi- in 2-fenilsulfonamida s CCR3 antagonistično aktivnostjo za zdravljenje astme in drugih vnetnih ali imunoloških obolenj
DK1765322T3 (da)	2014-02-10	Retinal-derivater og fremgangsmåder til anvendelse deraf i behandlingen af synsforstyrrelser
DK1951866T3 (da)	2014-10-27	Delta-9-elongaser og anvendelse heraf til fremstilling af flerumættede fedtsyrer
IL181706A0 (en)	2007-07-04	The treatment of inflammatory disorders and pain
DK2308507T3 (da)	2015-04-20	Fremgangsmåder til behandling af præeklampsi
DE602005003186D1 (de)	2007-12-20	Fluorkopolymer und dessen Verwendung
PL381765A1 (pl)	2007-07-09	Konstrukty wiążące i sposoby ich zastosowania
DK1974017T3 (da)	2014-02-10	Midler og fremgangsmåder til at påvirke stabiliteten af antistof producerende celler
EP1746902A4 (en)	2007-06-13	MULTI-LECTIN AFFINITY CHROMATOGRAPHY AND USES THEREOF
EP1799153A4 (en)	2013-03-13	STENT AND METHOD FOR PRODUCING THE STENT
DK1551860T3 (da)	2007-04-02	Glukokortikoid-receptorligander til behandling af stofskifteforstyrrelser
DK1487828T3 (da)	2009-02-02	Morpholinyl-urea-derivater til anvendelse til behandling af inflammatoriske sygdomme
ITMI20050704A1 (it)	2005-10-22	Dispositivo semiconduttore e metodo di produzione dello stesso
DK1701944T3 (da)	2009-11-09	2-(amino-substituerede)-4-aryl-pyramidiner og relaterede forbindelser til behandling af inflammationssygdomme
IS8497A (is)	2006-06-02	Aðferðir og hvarfefni til að meðhöndla bólgusjúkdóma
DE602005010151D1 (de)	2008-11-20	Photoleitfähiges Bildherstellungselement und dessen Herstellungsverfahren
DK1896077T3 (da)	2012-12-03	Fremgangsmåder og sammensætninger til forebyggelse og behandling af inflammatoriske sygdomme
EP2102874A4 (en)	2012-05-02	ELECTRIC MUFF AND METHOD FOR PRODUCING AN ELECTRIC MUFF
EP1741456A4 (en)	2010-10-20	ARTIFICIAL DURA MATER AND METHOD FOR THEIR PRODUCTION